Blue Owl Capital Holdings »

Dave shares owned by Blue Owl Capital Holdings

Quarter-by-quarter ownership of Dave (DAVEW) shares owned by Blue Owl Capital Holdings from 13F filings

Historical chart of Blue Owl Capital Holdings investment in Dave

Tip: Access up to 7 years of quarterly data

All positions including Dave held by Blue Owl Capital Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dave by Blue Owl Capital Holdings

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.4k 29k 0.05

More positions owned by Blue Owl Capital Holdings

Nuveen Churchill Direct Lend Com Shs (NCDL)
Klaviyo Com Ser A (KVYO)
Tourmaline Bio (TRML)
Pliant Therapeutics (PLRX)
Cullinan Oncology (CGEM)
Owl Rock Capital Corporation (OBDC)
Larimar Therapeutics (LRMR)
Proshares Tr Ultrapro Qqq (TQQQ)
Engene Holdings (ENGN)
Evercommerce (EVCM)
Acelyrin (SLRN)
Conduent Incorporate (CNDT)
Repare Therapeutics Ord (RPTX)
Context Therapeutics (CNTX)
Ultragenyx Pharmaceutical (RARE)

View all positions for Blue Owl Capital Holdings

Top funds holding Dave

LMR Partners
Corbin Capital Partners
Cowen And Company
Wolverine Asset Management
Intl Fcstone
Kepos Capital
Walled Lake Planning & Wealth Management
Jane Street
D. E. Shaw & Co
Atalaya Capital Management
Blue Owl Capital Holdings
Atlas Capital Advisors
Nomura Holdings
Goldman Sachs Group
Vestcor Investment Management Corp

View all funds holding Dave